SCHEMBL8309671

SCHEMBL8309671

COc1ccccc1C=C1SC(=S)NC1=O

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
NAT1 P18440 3/20 1.00
PDE4B Q07343 3/20 0.78
GSK3B P49841 1/20 0.73
CA2 P00918 1/20 0.70
PIM1 P11309 3/20 0.63
CISD1 Q9NZ45 2/20 0.62
MAOB P27338 1/20 0.62
PDE3A Q14432 1/20 0.61
PTP4A3 O75365 1/20 0.61
MYC P01106 1/20 0.59
MAX P61244 1/20 0.59
CSNK2A2 P19784 1/20 0.58
CLK1 P49759 1/20 0.58
CSNK2B P67870 1/20 0.58
CSNK2A1 P68400 1/20 0.58
DYRK1A Q13627 1/20 0.58
DYRK1B Q9Y463 1/20 0.58
MTOR P42345 1/20 0.58

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8309670 1.00 NAT1 (1.00) NAT1PDE4BGSK3BCA2PIM1
SCHEMBL18103028 0.92 NAT1 (0.85) NAT1PDE4BGSK3BCA2PIM1
SCHEMBL19999112 0.90 NAT1 (0.81) NAT1PDE4BGSK3BCA2PIM1
SCHEMBL8310325 0.88 PDE4B (1.00) NAT1PDE4BGSK3BCA2PIM1
SCHEMBL8310322 0.88 PDE4B (1.00) NAT1PDE4BGSK3BCA2PIM1
SCHEMBL18103022 0.87 NAT1 (0.77) NAT1PDE4BGSK3BCA2PIM1
SCHEMBL13499562 0.87 NAT1 (0.76) NAT1PDE4BGSK3BCA2PIM1
SCHEMBL8193222 0.87 NAT1 (0.76) NAT1PDE4BGSK3BCA2PIM1
SCHEMBL15347653 0.87 NAT1 (0.76) NAT1PDE4BGSK3BCA2PIM1
SCHEMBL8193225 0.87 NAT1 (0.76) NAT1PDE4BGSK3BCA2PIM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0915090-A1 Compounds useful as hypoglycemic agents and for treating Alzheimer's disease ELI LILLY AND COMPANY (US) 1999-05-12 EP disclosed
US-5716975-A NONTOXIC RHODANINE DERIVATIVES; ANTIDIABETIC AGENTS, CATHEPSIN D INHIBITORS, B-AMYLOID PROTEIN REDUCTION ELI LILLY AND COMPANY (US) 1998-02-10 US disclosed
US-5661168-A ADMINISTERING RHODANINE DERIVATIVES TO CONTROL DIABETES ELI LILLY AND COMPANY (US) 1997-08-26 US disclosed
US-5523314-A RHODANINE DERIVATIVES ELI LILLY AND COMPANY (US) 1996-06-04 US disclosed
EP-0587377-A2 Thiazolidinone derivatives as hypoglycemic agents and for treating Alzheimer's disease ELI LILLY AND COMPANY (US) 1994-03-16 EP disclosed